Samrat Pharmachem Financials
BSE: 530125
₹237.50
₹0.65
(0.27%)
As on 04-Sep-2026 13:47IST
Market cap
₹71 Cr
Revenue (TTM)
₹294 Cr
P/E Ratio
--
P/B Ratio
1
Div. Yield
0 %
Income Statement (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
293.83
|
285.86
|
281.58
|
310.65
|
221.75
|
179.02
|
|
|
|
|
|
|
Total Income
|
294.96
|
286.84
|
282.98
|
311.12
|
222.38
|
179.48
|
|
|
|
|
|
|
Total Expenditure
|
295.20
|
275.62
|
279.13
|
286.72
|
197.51
|
170.35
|
|
|
|
|
|
|
EBITDA
|
-1.37
|
10.24
|
2.45
|
23.93
|
24.24
|
8.67
|
|
|
|
|
|
|
Depreciation
|
0.74
|
0.65
|
0.65
|
0.64
|
0.59
|
0.49
|
|
|
|
|
|
|
EBIT
|
-2.11
|
9.58
|
1.80
|
23.28
|
23.64
|
8.18
|
|
|
|
|
|
|
Interest
|
0.63
|
0.67
|
0.69
|
1.23
|
0.67
|
1.28
|
|
|
|
|
|
|
Other Income
|
1.13
|
0.98
|
1.40
|
0.48
|
0.63
|
0.46
|
|
|
|
|
|
|
Exceptional Items
|
--
|
--
|
--
|
--
|
--
|
-0.02
|
|
|
|
|
|
|
Profit before Tax
|
-1.61
|
9.89
|
2.52
|
22.53
|
23.60
|
7.34
|
|
|
|
|
|
|
Provision for Tax
|
0.60
|
2.77
|
0.36
|
5.90
|
6.42
|
2.01
|
|
|
|
|
|
|
Profit after Tax
|
-2.21
|
7.11
|
2.16
|
16.63
|
17.18
|
5.33
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
68.18
|
71.80
|
65.00
|
63.14
|
46.82
|
29.64
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Non-Current Liabilities
|
0.41
|
0.11
|
0.34
|
0.25
|
0.46
|
0.43
|
|
|
|
|
|
|
Current Liabilities
|
55.82
|
49.58
|
56.40
|
53.19
|
37.33
|
27.33
|
|
|
|
|
|
|
Total Liabilities
|
124.42
|
121.49
|
121.74
|
116.59
|
84.61
|
57.40
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
16.65
|
18.13
|
19.17
|
17.54
|
13.35
|
10.07
|
|
|
|
|
|
|
Current Assets
|
103.79
|
103.36
|
102.57
|
99.05
|
71.26
|
47.32
|
|
|
|
|
|
|
Total Assets
|
124.42
|
121.49
|
121.74
|
116.59
|
84.61
|
57.40
|
|
|
|
|
|
|
Total Debt*
|
--
|
9.91
|
8.45
|
18.66
|
7.52
|
8.79
|
|
|
|
|
|
|
Net Current Assets
|
47.96
|
53.78
|
46.16
|
45.86
|
33.93
|
20.00
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
--
|
0.07
|
0.07
|
0.07
|
0.07
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-10.09
|
9.41
|
-9.44
|
17.47
|
4.80
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
0.00
|
-0.41
|
-3.00
|
-1.06
|
-2.92
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
0.48
|
-11.20
|
9.60
|
-1.95
|
-1.89
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
-9.62
|
-2.19
|
-2.84
|
14.46
|
-0.02
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
-7.15
|
23.02
|
7.00
|
53.83
|
55.62
|
17.26
|
|
|
|
|
|
|
Cash EPS (₹)
|
-7.15
|
25.14
|
9.09
|
55.91
|
57.54
|
18.86
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
223.50
|
232.39
|
210.37
|
204.37
|
151.54
|
95.92
|
|
|
|
|
|
|
Dividend per Share (₹)
|
--
|
1.00
|
1.00
|
1.00
|
1.00
|
--
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
-32.66
|
30.46
|
-30.54
|
56.56
|
15.53
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
-38.25
|
38.75
|
-26.87
|
34.71
|
3.58
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
13.61
|
4.13
|
34.91
|
52.33
|
23.90
|
|
|
|
|
|
|
ROE (%)
|
-3.18
|
10.40
|
3.38
|
30.25
|
44.95
|
19.77
|
|
|
|
|
|
|
ROA (%)
|
-1.80
|
5.85
|
1.81
|
16.53
|
24.20
|
9.22
|
|
|
|
|
|
|
EBIT Margin (%)
|
-0.72
|
3.35
|
0.64
|
7.50
|
10.66
|
4.57
|
|
|
|
|
|
|
Net Margin (%)
|
-0.75
|
2.48
|
0.76
|
5.35
|
7.73
|
2.97
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
2.72
|
1.00
|
5.56
|
8.02
|
2.85
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
4.68
|
1.52
|
-9.36
|
40.09
|
23.87
|
30.24
|
|
|
|
|
|
|
EBIT Growth (%)
|
-129.57
|
431.19
|
-92.25
|
-1.51
|
189.18
|
31.80
|
|
|
|
|
|
|
Net Profit Growth (%)
|
-145.87
|
228.87
|
-87.00
|
-3.23
|
222.22
|
25.88
|
|
|
|
|
|
|
EPS Growth (%)
|
-145.87
|
228.87
|
-87.00
|
-3.23
|
222.22
|
25.88
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
10.47
|
2.94
|
34.86
|
57.98
|
21.94
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
-33.11
|
13.59
|
47.64
|
6.89
|
8.72
|
7.88
|
|
|
|
|
|
|
Price / Book Value
|
1.03
|
1.35
|
1.59
|
1.82
|
3.20
|
1.42
|
|
|
|
|
|
|
Dividend Yield (%)
|
--
|
0.32
|
0.30
|
0.27
|
0.21
|
--
|
|
|
|
|
|
|
EV/EBITDA
|
-321.09
|
9.49
|
26.40
|
4.98
|
5.73
|
5.29
|
|
|
|
|
|
|
Close Price (₹)
|
219.65
|
312.75
|
333.45
|
371.10
|
484.80
|
136.00
|
|
|
|
|
|
|
High Price (₹)
|
389.00
|
646.00
|
604.30
|
1,250.00
|
578.00
|
159.00
|
|
|
|
|
|
|
Low Price (₹)
|
190.00
|
306.05
|
320.00
|
332.00
|
135.00
|
58.00
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
71.39
|
96.62
|
103.03
|
114.66
|
149.79
|
42.02
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
0.14
|
0.13
|
0.30
|
0.16
|
0.30
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
0.14
|
0.13
|
0.30
|
0.16
|
0.30
|
|
|
|
|
|
|
Current Ratio
|
1.86
|
2.08
|
1.82
|
1.86
|
1.91
|
1.73
|
|
|
|
|
|
|
Quick Ratio
|
1.08
|
1.32
|
1.45
|
1.25
|
1.58
|
1.31
|
|
|
|
|
|
|
Interest Coverage
|
-1.54
|
15.67
|
4.67
|
19.29
|
35.99
|
6.75
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
17.37
|
19.78
|
24.60
|
16.63
|
19.65
|
18.44
|
|
|
|
|
|
|
Asset Turnover
|
2.39
|
2.35
|
2.36
|
3.09
|
3.12
|
3.53
|
|
|
|
|
|
|
Receivable days
|
--
|
80.32
|
78.39
|
55.96
|
63.02
|
54.31
|
|
|
|
|
|
|
Inventory Days
|
--
|
37.46
|
34.48
|
26.40
|
19.60
|
26.94
|
|
|
|
|
|
|
Payable days
|
--
|
59.00
|
53.71
|
36.30
|
39.45
|
45.34
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
58.79
|
59.17
|
46.06
|
43.17
|
35.91
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
